CUT - Overview: Copper, Liver Tissue
Diagnosing Wilson disease and primary biliary cirrhosis using liver tissue specimens
CVRNA - Overview: Candida Vaginitis, Nucleic Acid Amplification RNA, Vaginal
Aiding in the diagnosis of Candida vaginitis This test is not intended for use in medico-legal applications.
CEE20 - Overview: CD20 Cell Expression Evaluation, Varies
Detecting cell-surface antigens on malignant cells that are potential therapeutic antibody targets, specifically CD20 Determining the eligibility of patients for monoclonal antibody therapies Monitoring response to the therapeutic...
CEE49 - Overview: CD49d Cell Expression Evaluation, Varies
Detecting cell-surface antigens on malignant cells that are potential therapeutic antibody targets, specifically CD49d Determining the eligibility of patients for monoclonal antibody therapies Monitoring response to the therapeutic...
HCQ - Overview: Hydroxychloroquine, Serum
Monitoring serum hydroxychloroquine concentrations, assessing compliance, and adjusting dosage in patients
GCLIP - Overview: Phospholipid (Cardiolipin) Antibodies, IgG, Serum
The following clinical situations, when used in conjunction with other criterial antiphospholipid antibody tests: -Unexplained arterial or venous thrombosis -A history of pregnancy morbidity defined as 1 or more unexplained deaths of a...
PBDV - Overview: Lead, Venous, with Demographics, Blood
Detecting lead toxicity in venous blood specimens
B2GMG - Overview: Beta-2 Glycoprotein 1 Antibodies, IgG and IgM, Serum
Evaluating patients with suspected antiphospholipid syndrome by identification of beta-2 glycoprotein 1 IgM and IgG antibodies First-line test when antiphospholipid syndrome is strongly suspected in conjunction with cardiolipin antibodies...
MCLIP - Overview: Phospholipid (Cardiolipin) Antibodies, IgM, Serum
The following clinical situations, when used in conjunction with other criterial antiphospholipid antibody tests: -Unexplained arterial or venous thrombosis -A history of pregnancy morbidity defined as 1 or more unexplained deaths of a...
HBAGP - Overview: Hepatitis B Virus Surface Antigen Prenatal, Serum
Diagnosis of acute, recent, or chronic hepatitis B Determination of chronic hepatitis B status Screening pregnant women for evidence of chronic hepatitis B (or hepatitis B carrier state) to identify neonates who are at high risk of...
A1R - Overview: A1 Antigen Subtype, Blood
Additional proof of alloantibody specificity Assessment of solid organ transplantation donor compatibility This test is not useful for the purpose of establishing paternity.
PWAS - Overview: Prader-Willi/Angelman Syndrome, Molecular Analysis, Varies
Confirmation of diagnosis in patients suspected of having either Prader-Willi syndrome (PWS) or Angelman syndrome (AS) based on clinical assessment or previous laboratory analysis Prenatal diagnosis in families at risk for PWS or AS
HCVDR - Overview: Hepatitis C Virus Genotypic Antiviral Drug Resistance, Serum
Detecting and identifying codon substitutions in the hepatitis C virus (HCV) NS3, NS5A, and NS5B genomic regions that confer resistance to current direct-acting antiviral drugs used for treatment of chronic hepatitis C infection due to HCV...
Detection of high-risk (HR) genotypes associated with the development of cervical cancer Aids in triaging women with abnormal Pap smear results Individual genotyping of human papillomavirus (HPV)-16 and/or HPV-18 if present Results of...
AFXN - Overview: Friedreich Ataxia, Repeat Expansion Analysis, Varies
Molecular confirmation of clinically suspected Friedreich ataxia
RETZZ - Overview: Multiple Endocrine Neoplasia Type 2 Syndrome, RET, Full Gene Analysis, Varies
Evaluating patients with a personal or family history suggestive of a multiple endocrine neoplasia type 2 (MEN2) or Hirschsprung disease (HSCR) Establishing a diagnosis of MEN2 or HSCR allowing for targeted cancer surveillance based on...
CLPMG - Overview: Phospholipid (Cardiolipin) Antibodies, IgG and IgM, Serum
The following clinical situations: -Unexplained arterial or venous thrombosis -A history of pregnancy morbidity defined as 1 or more unexplained deaths of a morphologically normal fetus beyond the 10th week of gestation, 1 or more premature...
HBGSN - Overview: Hepatitis B Virus Surface Antigen Screen, Serum
Diagnosis of acute, recent, or chronic hepatitis B Determination of chronic hepatitis B status This test is not offered as a screening or confirmatory test for blood donor specimens. This test is not useful for diagnosis of hepatitis...
HCVSP - Overview: Hepatitis C Virus (HCV) Antibody Screen Prenatal, Serum
Screening of pregnant women for hepatitis C virus (HCV) infection in primary care settings, with or without risk factors for hepatitis C This test should not be used as a screening test for hepatitis C in blood or human cells/tissue...
AGABS - Overview: Alpha-Galactosidase, Blood Spot
Diagnosis of Fabry disease in male patients using blood spot specimens Verifying abnormal serum alpha-galactosidase results in male patients with a clinical presentation suggestive of Fabry disease Follow-up to an abnormal newborn screen...
PKUBS - Overview: Phenylalanine and Tyrosine, Blood Spot
Monitoring effectiveness of therapy in patients with hyperphenylalaninemia This test is not sufficient for follow-up for abnormal newborn screening results or for establishing a diagnosis of a specific cause of hyperphenylalaninemia
PKUSC - Overview: Phenylalanine and Tyrosine, Self-Collect, Blood Spot
Monitoring effectiveness of therapy in patients with hyperphenylalaninemia in a patient-collected specimen This test is not sufficient for follow-up for abnormal newborn screening results or for establishing a diagnosis of a specific...
EAG - Overview: Hepatitis B Virus e Antigen, Serum
Determining the presence or absence of detectable hepatitis B virus e antigen in monitoring infection status of individuals with chronic hepatitis B Determining infectivity of hepatitis B virus (HBV) carriers Monitoring serologic...
HEAB - Overview: Hepatitis B Virus e Antibody, Serum
Determining the presence or absence of detectable hepatitis B virus e antibody in monitoring infection status of individuals with chronic hepatitis B Determining infectivity of hepatitis B virus (HBV) carriers Monitoring serologic...
COWB - Overview: Cobalt, Blood
Monitoring exposure to cobalt using whole blood specimens Monitoring metallic prosthetic implant wear This test is not useful for assessment of vitamin B12 activity.
ABONR - Overview: ABO/Rh Newborn, Blood
Selecting compatible blood products for transfusion therapy Determining the need for Rh immune globulin in mother of baby
SHUR - Overview: Schistosoma Exam, Random, Urine
Aiding in the diagnosis of schistosomiasis infections involving the urinary tract
LAPYP - Overview: Lactate Pyruvate Panel, Plasma
Diagnosing and monitoring patients with lactic acidosis Monitoring lactate-to-pyruvate ratios
PBDC - Overview: Lead, Capillary, with Demographics, Blood
Detecting lead toxicity with capillary collections
CD4NY - Overview: CD4 Count for Monitoring, New York, Blood
Only orderable by New York clients Serial monitoring of CD4 T-cell count in patients who are HIV-positive Follow-up and diagnostic evaluation of primary cellular immunodeficiencies, including severe combined immunodeficiency T-cell...
ATR - Overview: Isoagglutinin Titer, Anti-A, Serum
Evaluation of individuals with possible hypogammaglobulinemia Investigation of suspected roundworm infections
BTR - Overview: Isoagglutinin Titer, Anti-B, Serum
Evaluation of individuals with possible hypogammaglobulinemia
3A5Q - Overview: Cytochrome P450 3A5 Genotype, Varies
Aids in optimizing treatment with tacrolimus and other drugs metabolized by cytochrome P450 3A5
HEAG - Overview: Hepatitis B Virus e Antigen and Hepatitis B Virus e Antibody, Serum
Determining the presence or absence of detectable hepatitis B virus e antigen and antibody in monitoring infection status of individuals with chronic hepatitis B Determining infectivity of hepatitis B virus (HBV) carriers Monitoring...
HBNTP - Overview: Hepatitis B Virus Surface Antigen Confirmation, Prenatal, Serum
Diagnosis of acute, recent, or chronic hepatitis B in prenatal patients This test is not useful during the "window period" of acute hepatitis B (ie, after disappearance of hepatitis B virus surface antigen [HBsAg] and prior to appearance...
RISAP - Overview: Risankizumab Quantitation with Antibodies, Serum
Evaluation of patients with limited primary (initial) response to or secondary loss of response to risankizumab
SALCA - Overview: Salicylate, Serum
Quantitative determination of toxic levels of salicylate This test is not useful for assessing low-dose aspirin therapy.
ETX - Overview: Ethosuximide, Serum
Monitoring ethosuximide therapy Determining compliance Assessing ethosuximide toxicity
ABOMR - Overview: ABO/Rh, Blood
Determining blood group ABO and Rh only
OXYMU - Overview: Oxymorphone Confirmation, Random, Urine
Detection and quantification of oxymorphone and noroxymorphone in urine
DCTR - Overview: Direct Antiglobulin Test (Polyspecific), Blood
Demonstrating in vivo coating of red blood cells with IgG or the complement component C3d in the following settings: -Autoimmune hemolytic anemia -Hemolytic transfusion reactions -Drug-induced hemolytic anemia
CATTR - Overview: Cold Agglutinin Titer, Serum
Detection of cold agglutinins in patients with suspected cold agglutinin disease This test is not recommended to diagnose Mycoplasma pneumoniae infections.
CAFF - Overview: Caffeine, Serum
Monitoring caffeine therapy in neonates Assessing caffeine toxicity in neonates
Detecting drug use involving stimulants, barbiturate, benzodiazepines, cocaine, opioids, tetrahydrocannabinol, alcohol, and nicotine This test is not intended for use in employment-related testing.
PSPTG - Overview: Phosphatidylserine/Prothrombin Antibody, IgG, Serum
Detecting IgG antibodies against phosphatidylserine/prothrombin complex in patients with strong suspicion of antiphospholipid syndrome (APS) who are negative for the APS criteria laboratory tests (lupus anticoagulant, IgG and IgM...
Detection and differentiation between recent, past/resolved, or chronic hepatitis B Diagnosis of recent hepatitis B virus (HBV) infection during the "window period" when both hepatitis B surface (HBs) antigen and anti-HBs are negative...
HBC - Overview: Hepatitis B Virus Core Total Antibodies, Serum
Diagnosis of recent or past hepatitis B Determination of occult hepatitis B in otherwise healthy hepatitis B virus carriers with negative test results for hepatitis B surface (HBs) antigen, anti-HBs, anti-HB core IgM, hepatitis Be (HBe)...
GP210 - Overview: GP210 Antibody, IgG, Serum
Evaluating the risk of primary biliary cholangitis in anti-mitochondrial antibody (AMA)-negative patients by identification of gp210 antibodies Estimating risk in AMA-positive patients with incomplete feature of disease
SP100 - Overview: SP100 Antibody, IgG, Serum
Evaluating the risk of primary biliary cholangitis in anti-mitochondrial antibody (AMA) negative patients by identification of Sp100 antibodies Estimating risk in AMA-positive patients with incomplete feature of disease
TALDO - Overview: Polyols, Quantitative, Urine
Diagnosing deficiencies of transaldolase, transketolase, sedoheptulose, or ribose-5-phosphate isomerase
Register today for Classical Hematology 2023 - Insights
Taking place on October 3–4, 2023, in Rochester, Minnesota, the Classical Hematology 2023 conference focuses on addressing the evaluation of frequently encountered blood count abnormalities. The conference...
Visit Mayo Clinic Laboratories at Medlab Middle East 2023 - Insights
announce our participation in Medlab Middle East 2023, a medical conference and exhibition taking place in Dubai, United Arab Emirates, Feb. 6–9, 2023....
Top 5 Mayo Clinic Laboratories advancements in 2024 - Insights
Five of the most significant advancements from Mayo Clinic Laboratories in 2024 to enhance diagnostics and patient care globally....
Visit Mayo Clinic Laboratories at Medlab Middle East 2024 - Insights
announce our participation in Medlab Middle East 2024, a medical conference and exhibition taking place in Dubai, United Arab Emirates, Feb. 5–8, 2024....
Managing Compliance in Preparation for 2025 Updates - Insights
With updates expected to federal compliance guidance for laboratories in 2025, now is a great time to revisit existing guidelines and plans....